Key result
Elderly age (≥65 years) was associated with a significantly higher rate of anticholinergic prescriptions compared to age ≤64 years (11.3% vs 3.8%), reaching 43.8% in special care home residents.
Why the study?
What is the prevalence and pattern of anticholinergic medication prescribing in the elderly compared to younger populations?
Observational
What is the prevalence and pattern of anticholinergic medication prescribing in the elderly compared to younger populations?
Absolute Event Rate: 11.3% vs 3.8%
The elderly, particularly those in special care homes or with dementia, are at high risk of receiving anticholinergic prescriptions, often at high doses or concurrently, which may cause significant adverse clinical consequences.
No takes yet. Share an insight, caveat, or question.
May warrant deprescribing reviews in elderly care home residents; leaves open whether reducing anticholinergic burden improves outcomes.
Alfred J. Rémillard (1996) conducted an observational in Elderly patients. Elderly age (≥ 65 years) vs. Age ≤ 64 years was evaluated on Prescription for an anticholinergic medication. Elderly age (≥65 years) was associated with a significantly higher rate of anticholinergic prescriptions compared to age ≤64 years (11.3% vs 3.8%), reaching 43.8% in special care home residents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: